CNXUNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends October 31
Conexeu Sciences Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$3.29+0.23 (+7.52%)
Close on Oct 19, 2026
- Market cap
- $88.74M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Conexeu Sciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Conexeu Sciences filed with the SEC
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap
Regulation FD disclosure · EX-99.1 to Form 8-K